The WMAS produces and contributes to a range of medicines-related publications for healthcare professionals and members of the public.
You may also want to visit our medicines guidance for healthcare professionals page.
Monkeypox Advice
A separate monkeypox page has been created to house information and advice for healthcare professionals regarding human monkeypox infections.
Ukrainian Medicines Resources
Healthcare professionals can access information to help identify and translate medication details for Ukrainian refugees via our recent blog post.
Porphyria
Medicines that are considered safe for use in the acute porphyrias
Using haem arginate (human hemin) in acute porphyria attacks
Travel – a guide for people with acute porphyria (available in Welsh)
Prescribing restrictions in non-acute cutaneous porphyria (available in Welsh)
Safety of topical medicines in porphyria
Acne treatment in those with acute porphyria (available in Welsh)
Safety of dental medicines in acute porphyria
Making safe medicine choices during general anaesthesia and surgery in acute porphyria
Complementary Medicines
- Advising patients using turmeric on its potential adverse effects
- Advising patients using turmeric on its potential interactions
Cardiff & Vale UHB prescribing resources
Good Prescribing Guide and INFORM Formulary
The Good Prescribing Guide is available on the Eolas medical app via the Apple App Store and Google play store
The Guide is intended to supplement the British National Formulary and Cardiff and Vale INFORM Formulary and to provide information on local practices within the University Health Board. The guidelines are intended for adult secondary care practice. The Department of Child Health in Cardiff and Vale University Health Board produce Clinical Guidelines for use in paediatrics.
Other publications
This medicines update in Archives of Disease in Childhood – Education and Practice reviewed international practices for the administration of aminoglycosides by intravenous injection or infusion. It questions if we could use IV injection more in certain circumstances. It was adapted from a review produced by WMIC for the Neonatal and Paediatric Pharmacy Group (NPPG):
Manning A, Burgess A. Aminoglycoside administration in paediatrics: a literature search comparing international practices of intravenous injection or intravenous infusion. Arch Dis Child Educ Pract Ed. 2024; Published Online First: 09 April 2024. doi: 10.1136/archdischild-2024-326924
The following letter to the editor highlights three cases of COVID-19 “rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy from the cohort of patients treated by the National Antiviral Service (NAVS):
Coulson JM, Adams A, Gray LA, Evans A. COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy. J Infect. 2022; S0163-4453(22)00363-2. Online ahead of print. doi: 10.1016/j.jinf.2022.06.011
The following article was adapted from a review commissioned and written by the WMIC for the Neonatal and Paediatric Pharmacists Group:
McArtney R, Bailey A, Champion H. What is a ketogenic diet and how does it affect the use of medicines? Arch Dis Child Educ Pract Ed. 2017; 102:194-9.
In conjunction with the Department of Biochemistry and Immunology, University Hospital of Wales, WMIC has published two articles on safe prescribing in the acute porphyrias:
Lockett CD and Badminton MN. Safe prescribing in the autosomal dominant acute porphyrias: a practical approach: Part I. Adverse Drug Reaction Bulletin. August 2015; No. 293: pp. 1131 – 1134
Lockett CD and Badminton MN. Safe prescribing in the autosomal dominant acute porphyrias: a practical approach: Part II. Adverse Drug Reaction Bulletin. October 2015; No. 294: pp. 1135 – 1138
04 Feb 25
UKMi Q&A and National COVID-19 treatment PGD sections removed.
22 Oct 24
Turmeric Q&As added.
13 Sep 24
Good Prescribing Guide link updated.
17 Apr 24
Aminoglycosides article details added.
28 Feb 24
Broken link updated.
03 Oct 23
Welsh translation of ‘Travel – a guide for people with acute porphyria’ uploaded.
02 Oct 23
Latest version of ‘Travel – a guide for people with acute porphyria’ uploaded.
28 Sept 23
Welsh translation of ‘Prescribing restrictions in non-acute cutaneous porphyria’ uploaded.
19 Sept 23
Welsh translation of ‘Acne treatment in those with acute porphyria’ uploaded.
22 Aug 23
Latest update of ‘Acne treatment in those with acute porphyria’ uploaded.
05 Jul 23
Links to porphyria Q&As updated.
07 Sep 22
National COVID-19 treatment PGD templates moved to NAVS healthcare professionals page.
01 Jul 22
National COVID-19 treatment PGD templates updated.
22 Jun 22
COVID-19 “Rebound” article added. Links to articles on SPS website updated.
14 Jun 22
Monkeypox advice added.
21 Apr 22
Ukrainian Medicines Resources added.
30 Mar 22
National COVID-19 treatment PGD templates updated.
09 Feb 22
Paxlovid PGD added.
31 Jan 22
Sotrovimab PGD template updated.
07 Jan 22
Molnupiravir PGD and sotrovimab PGD template updated.
17 Dec 21
Sotrovimab PGD template added and Ronapreve PGD template updated.
15 Dec 21
National COVID-19 treatment PGD templates added.
24 Sep 21
COVID-19 Vaccine advice updated.
10 Sep 21
Advice on COVID-19 Vaccine third primary dose for immunosuppressed individuals added
